Patent · US Active

RSV-specific binding molecules and means for producing them

US8562996B2 · kind B2 · utility

19Cited by
112References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 30, 2008
Grant dateOct 22, 2013
Priority date—
Expiry dateSep 18, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides antibodies and functional equivalents thereof which are capable of specifically binding RSV, and means and methods for producing them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.